Permutation and Bootstrap Testing for the Sequential Parallel Comparison Design

Sequential parallel comparison design (SPCD) was proposed to reduce placebo response in randomized trials with placebo comparators. This design is achieved by randomizing subjects between placebo and drug in stage 1 and after the parallel first stage, participants who do not respond to placebo in st...

Full description

Saved in:
Bibliographic Details
Published inStatistics in biopharmaceutical research Vol. 11; no. 1; pp. 44 - 51
Main Authors Silverman, Rachel, Fine, Jason, Zink, Richard C., Ivanova, Anastasia
Format Journal Article
LanguageEnglish
Published Taylor & Francis 02.01.2019
Subjects
Adaptive design
Bootstrap tests
Permutation test
Placebo response
Sequential parallel comparison design
Online AccessGet full text
ISSN1946-6315
1946-6315
DOI10.1080/19466315.2018.1549095

Cover

Abstract Sequential parallel comparison design (SPCD) was proposed to reduce placebo response in randomized trials with placebo comparators. This design is achieved by randomizing subjects between placebo and drug in stage 1 and after the parallel first stage, participants who do not respond to placebo in stage 1 are randomly re-assigned to treatment or placebo in stage 2. The efficacy analysis of the study data includes all data from stage 1 and all placebo nonresponding participants from stage 2. This article examines the validity of permutation and bootstrap testing for SPCD. We examine two permutation tests and three bootstrap tests for SPCD and give recommendations on which test to use.
AbstractList Sequential parallel comparison design (SPCD) was proposed to reduce placebo response in randomized trials with placebo comparators. This design is achieved by randomizing subjects between placebo and drug in stage 1 and after the parallel first stage, participants who do not respond to placebo in stage 1 are randomly re-assigned to treatment or placebo in stage 2. The efficacy analysis of the study data includes all data from stage 1 and all placebo nonresponding participants from stage 2. This article examines the validity of permutation and bootstrap testing for SPCD. We examine two permutation tests and three bootstrap tests for SPCD and give recommendations on which test to use.
Author Zink, Richard C.
Ivanova, Anastasia
Fine, Jason
Silverman, Rachel
Author_xml – sequence: 1
  givenname: Rachel
  surname: Silverman
  fullname: Silverman, Rachel
  email: rachel.silverman1@merck.com
  organization: Department of Biostatistics, The University of North Carolina
– sequence: 2
  givenname: Jason
  surname: Fine
  fullname: Fine, Jason
  organization: Department of Biostatistics, The University of North Carolina
– sequence: 3
  givenname: Richard C.
  surname: Zink
  fullname: Zink, Richard C.
  organization: TARGET PharmaSolutions Inc
– sequence: 4
  givenname: Anastasia
  surname: Ivanova
  fullname: Ivanova, Anastasia
  organization: Department of Biostatistics, The University of North Carolina
BookMark eNqFkN1KAzEQRoMo2FYfQcgLtCa7SXYXb9T6C4UWrNdhupvUSDapSYr07d2lFcQLnZsZEs7HzBmiY-edQuiCkgklJbmkFRMip3ySEVpOKGcVqfgRGvTv4_7j-Md8ioYxvhMiGCV8gOYLFdptgmS8w-AafOt9iinABi9VTMatsfYBpzeFX9THVrlkwOIFBLBWWTz17QaCiR18p6JZuzN0osFGdX7oI_T6cL-cPo1n88fn6c1sXOe8SGNKGshKgJpSRllBhdBsleeiq6LShWIqqwiljVIrBaIsdc2yTHOoS5HzLiEfoat9bh18jEFpWZv9Fd3uxkpKZO9GfruRvRt5cNPR_Be9CaaFsPuXu95zxnVWWvj0wTYywc76oAO42kSZ_x3xBXzsfWo
CitedBy_id crossref_primary_10_1080_10543406_2022_2080695
crossref_primary_10_3390_su151612491
crossref_primary_10_1002_sim_9381
crossref_primary_10_1080_19466315_2021_1924257
crossref_primary_10_3389_fenrg_2023_1238416
crossref_primary_10_1080_10543406_2020_1818252
Cites_doi 10.1214/aoms/1177707045
10.1159/000069738
10.1002/sim.7635
10.1007/978-1-4899-4541-9
10.1198/sbr.2010.08015
10.1007/b97553
10.1016/j.cct.2011.04.006
10.1016/S0924-9338(01)00600-9
10.1038/npp.1994.63
10.1159/000332050
10.4155/cli.13.74
10.1002/sim.4292
ContentType Journal Article
Copyright 2019 American Statistical Association 2019
Copyright_xml – notice: 2019 American Statistical Association 2019
DBID AAYXX
CITATION
DOI 10.1080/19466315.2018.1549095
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1946-6315
EndPage 51
ExternalDocumentID 10_1080_19466315_2018_1549095
1549095
Genre Article
GroupedDBID .7F
0BK
0R~
30N
AAAVZ
AAJMT
AALDU
AAMIU
AAPUL
AAQRR
ABCCY
ABDBF
ABFIM
ABLIJ
ABPAQ
ABPEM
ABXUL
ABXYU
ACGFS
ACTIO
ACUHS
ADCVX
ADGTB
ADMSI
AEISY
AENEX
AEYOC
AGDLA
AHDSZ
AHDZW
AIJEM
AKBVH
AKOOK
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AQRUH
AWYRJ
BLEHA
CCCUG
DGEBU
DKSSO
EBD
EBS
EJD
GTTXZ
H13
HZ~
I-F
J~4
KYCEM
LJTGL
M4Z
O9-
P2P
RNANH
ROSJB
RTWRZ
TBQAZ
TDBHL
TEJ
TFL
TFT
TFW
TTHFI
TUROJ
TUS
UU3
WZA
ZGOLN
AAGDL
AAHIA
AAYXX
ABJNI
ADYSH
AFRVT
AIYEW
CITATION
ID FETCH-LOGICAL-c357t-10da28aac114147166f4b33666679f7e4e29011deebea688fc422f5ac86353573
ISSN 1946-6315
IngestDate Tue Jul 01 01:29:29 EDT 2025
Thu Apr 24 23:02:48 EDT 2025
Wed Dec 25 09:08:30 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c357t-10da28aac114147166f4b33666679f7e4e29011deebea688fc422f5ac86353573
OpenAccessLink https://figshare.com/articles/journal_contribution/Permutation_and_Bootstrap_Testing_for_the_Sequential_Parallel_Comparison_Design/8020976
PageCount 8
ParticipantIDs informaworld_taylorfrancis_310_1080_19466315_2018_1549095
crossref_citationtrail_10_1080_19466315_2018_1549095
crossref_primary_10_1080_19466315_2018_1549095
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 1/2/2019
2019-01-02
PublicationDateYYYYMMDD 2019-01-02
PublicationDate_xml – month: 01
  year: 2019
  text: 1/2/2019
  day: 02
PublicationDecade 2010
PublicationTitle Statistics in biopharmaceutical research
PublicationYear 2019
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
References CIT0010
CIT0001
CIT0012
CIT0011
CIT0003
CIT0002
CIT0005
Zink R.C. (CIT0014) 2017
CIT0004
CIT0007
Wasserman L (CIT0013) 2006
CIT0006
CIT0009
CIT0008
References_xml – volume-title: All of Nonparametric Statistics
  year: 2006
  ident: CIT0013
– ident: CIT0003
  doi: 10.1214/aoms/1177707045
– ident: CIT0005
  doi: 10.1159/000069738
– ident: CIT0011
  doi: 10.1002/sim.7635
– ident: CIT0004
  doi: 10.1007/978-1-4899-4541-9
– ident: CIT0007
  doi: 10.1198/sbr.2010.08015
– ident: CIT0010
  doi: 10.1007/b97553
– volume-title: Analysis of Clinical Trials Using SAS: A Practical Guide
  year: 2017
  ident: CIT0014
– ident: CIT0002
  doi: 10.1016/j.cct.2011.04.006
– ident: CIT0009
  doi: 10.1016/S0924-9338(01)00600-9
– ident: CIT0012
  doi: 10.1038/npp.1994.63
– ident: CIT0006
  doi: 10.1159/000332050
– ident: CIT0001
  doi: 10.4155/cli.13.74
– ident: CIT0008
  doi: 10.1002/sim.4292
SSID ssj0064105
Score 2.1178415
Snippet Sequential parallel comparison design (SPCD) was proposed to reduce placebo response in randomized trials with placebo comparators. This design is achieved by...
SourceID crossref
informaworld
SourceType Enrichment Source
Index Database
Publisher
StartPage 44
SubjectTerms Adaptive design
Bootstrap tests
Permutation test
Placebo response
Sequential parallel comparison design
Title Permutation and Bootstrap Testing for the Sequential Parallel Comparison Design
URI https://www.tandfonline.com/doi/abs/10.1080/19466315.2018.1549095
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9tAEF7c9NJLadOWpi_2UHJx5Ere1Wp1TNOGEGhqGgVCL2L1IoIgmVguuL8-M57Vw3Ho87IY2TuGnU-7M7Mz3zD2PvWN8U1YOHkGg0zAYTVephxdKGk8oaVwsRr5y5k6uZCnl_7laLQaZC0tm2SS_ry3ruRftArPQK9YJfsXmu2EwgP4DPqFETQM4x_peAbb6tKmC2IA_GNdNxi6mI8jJM-wOZJoWp6vM6YbDI_PzA32T7mmrYBaEH7q8zisoYpGqOVwLqtxUtbzq43gtyUJ6oLJ5yWmWNtw6jdkie5SN45LipqemkV_5_8dfOBBYf_4aNKBFGz7-geFeysDxuuiNMPYBJZDeY7be7LRVpsQOnVoqw2lcpSgYs5uL_a2MEcbK5FE2iOaKGq3Nn_KlkS5KBbT9jQGzkKX2nje4dW23zxgD6dBsL7hF-5Ze4grzH5tC760--FeoRumzAbR7cBEiZ6wx9a34IcElKdslFe7bH9Gilsd8KivtVsc8H0-62nLV8_Y1wGaOKCJd2jiFk0c_poDmniPJt6iifdo4oSm5-zi-HN0dOLYdhtOKvyggQM5M1NtTAousgc2i1KFTIQA_1YFYRHkMsc7dy_L4b03SusildNp4ZtUg9EKEsQLtlPVVf6ScfA6fNdLChd-KjX4sMZkYRJkKYgEyXKPyXbl4tRy0WNLlOvYs5S17YLHuOCxXfA9NummzYmM5XcTwqFa4mYNyIKwGItfzn31H3Nfs0f96_CG7TQ3y_wtGK9N8m4Ns1u7H5fi
linkProvider Taylor & Francis
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELagDLDwRpSnB9SpKUnsOMkIhapAWyKRSt0ix4kZqNKqpEP59Zzz6AMJGLpkSc6yz5fz3fnuO4RuhMW5xV2pxRE8aAgOKzcipjmSUW4QhxJdVSN3e6zdp88Da7BUC6PSKpUPLXOgiExXq59bBaPLlLhbQ4GiE8NSmVmOio24YChsoi0LbHcl5UTvldqYqTTGsnLnN9KVM2kFsXTprGntIVHOMk8x-WhM07Ahvn4AOK63jH20W5ii-C6XnQO0ESeHqOblWNazOvYXpVmfdVzD3gLlenaEXj3Q6dP8Ih_DHPD9aJSquMkY-wq5I3nHsEAM9iV-y9K1QZUMsccnqnnLEDfn_Q_xQ5ZEcoz6rUe_2daK7gyaIJadgv6OuOlwLsCjMuCIY0zSkBDYAWa70o5prK5ojSgGMeHMcaSgpiktLhywcWAEcoIqySiJTxEGI9XSjVDq8Cl1wOXhPHJDOxIwJIxMq4iW-xOIArpcddAYBkaBcFqyMlCsDApWVlFjTjbOsTv-I3CXNz9Is6CJzDucBORP2rM1aK_RdtvvdoLOU-_lHO3AKzeL8pgXqJJOpvEl2D1peJUJ9jfwqPX2
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELagSIiFN6I8PaBOTYljx3FGaKnKq0Sildgi52EGqrRq06H8es559IEEDCxZkrPss3O-O3_-DqGr0JbSlq4y4ggeLICAVZKIG0JxJgkVjJr6NvJzl3f67OHNLtGEkwJWqWNolRNFZLZa_9yjSJWIuGuiOdEpsTUwS-jUiAt-wjra4OCeaFQfNbulMeYaxVhe3PlJdGVLWiEsXdpq2jsoKDuZI0w-GtM0aISf3_gb_zWKXbRdOKL4Jl85e2gtTvZRzcuZrGd13FtczJrUcQ17C47r2QF68cCiT_NjfAxdwLfDYaqzJiPc07wdyTuG8WHwLvFrBtYGQzLAnhzr0i0D3JxXP8StDEJyiPrtu16zYxS1GYyQ2k4K1juSlpAyhHiKwAbHuWIBpRAMccdVTsxifUBLohgWieRCqJBZlrJlKMDDgRboEaokwyQ-RhhcVNskgTLhUyYg4JEycgMnCqFJaJlVESunxw8L4nJdP2Pgk4LftFSlr1XpF6qsosZcbJQzd_wl4C7PvZ9mKROV1zfx6a-yJ_-QvUSbXqvtP913H0_RFrxxsxSPdYYq6Xgan4PTkwYX2bL-Aueb9Jo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Permutation+and+Bootstrap+Testing+for+the+Sequential+Parallel+Comparison+Design&rft.jtitle=Statistics+in+biopharmaceutical+research&rft.au=Silverman%2C+Rachel&rft.au=Fine%2C+Jason&rft.au=Zink%2C+Richard+C.&rft.au=Ivanova%2C+Anastasia&rft.date=2019-01-02&rft.pub=Taylor+%26+Francis&rft.eissn=1946-6315&rft.volume=11&rft.issue=1&rft.spage=44&rft.epage=51&rft_id=info:doi/10.1080%2F19466315.2018.1549095&rft.externalDocID=1549095
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1946-6315&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1946-6315&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1946-6315&client=summon